Topical delivery of enoxaparin using nanostructured lipid carrier

References

• Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, Dietrich-Neto F. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. New Eng J Med, 2002;246(13):975–80
   Google Scholar
• Betz G, Nowbakht P, Imboden R, Imanidis G. Heparin penetration into and permeation through human skin from aqueous and liposomal formulation in-vitro. Int J Pharm, 2001;228(1–2):147–59
   PubMedGoogle Scholar
• Bhaskar K, Anbu J, Ravichandiran V, Venkateswarlu V, Rao YM. Lipid nanoparticles for transdermal delivery of flurbiprofen: Formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis, 2009;8:1–15
   PubMed Web of Science ®Google Scholar
• Bunjes H, Westesen K, Koch MHJ. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm, 1996;129:159–73
   Web of Science ®Google Scholar
• Draize J, Woodward G, Calvery HO. Methods for the study of irritation and toxicity of substances topically applied to skin and mucuos membranes. J Pharmacol Exp Ther, 1944;82:377–90
   Web of Science ®Google Scholar
• Gafe F, Wohlrab W, Neubert RH, Brandsch M. Transport of biotin in human keratinocytes. J Investigat Dermatol, 2003;120(3):428–33
   PubMed Web of Science ®Google Scholar
• Greer IA, Nelson-Piercy C. Low molecular weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy. Blood, 2005;106:401–7
   PubMed Web of Science ®Google Scholar
• Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficiency, and safety. Chest, 2001;119(1):64S–94S
   Web of Science ®Google Scholar
• Hofmann T. Clinical application of enoxaparin. Exp Rev Cardiovasc Ther, 2004;2(3):321–37
   PubMedGoogle Scholar
• Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surfaces B, 2005;45(3–4):167–73
   PubMed Web of Science ®Google Scholar
• Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm, 2006;314:83–89
   PubMed Web of Science ®Google Scholar
• Investigational New Drug Application, US Department of Health and Human Services. [Online] Available at: http://www.hhs.gov. Accessed 13 March 2013
   Google Scholar
• Jain S, Jain P, Umamaheswari RB, Jain NK. Transfersomes – A novel vesicular carrier for enhanced transdermal delivery: Development, characterization and performance evaluation. Drug Dev Ind Pharm, 2003;29:1013–26
   PubMed Web of Science ®Google Scholar
• Jain S, Umamaheshwari RB, Bhadra D, Jain NK. Ethosomes: A novel vesicular carrier for enhanced transdermal delivery of an anti HIV agent. Ind J Pharm Sci, 2004;66(1):72–81
   Google Scholar
• Jenning V, Thünemann AF, Gohla SH. Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm, 2000;199(2):167–77
   PubMed Web of Science ®Google Scholar
• Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mader K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release, 2004;95(2):217–27
   PubMed Web of Science ®Google Scholar
• Jores K, Mehnert W, Mader K. Physicochemical investigations of solid lipid nanoparticles and oil loaded solid lipid nanoparticles: A nuclear magnetic resonance and electron spin resonance study. Pharm Res, 2003;20(8)1274–83
   PubMed Web of Science ®Google Scholar
• Khurana S, Utreja P, Tiwary AK, Jain NK, Jain, S. Nanostructured lipid carriers and their application in drug delivery. Int J Biomed Eng Tech, 2009;2(2):152–71
   Google Scholar
• Levy JH, Tanaka KA, Hursting MJ. Reducing thrombotic complications in the perioperative setting: An update on heparin induced thrombocytopenia. Anesth Analg, 2007;105(3):570–82
   PubMed Web of Science ®Google Scholar
• Maaßen S, Schwarz C, Mehnert W, Lucks JS, Yunis-Specht F, Muller BW, et al. Comparison of cytotoxicity between polyester nanoparticles and solid lipid nanoparticles (SLN). Proceedings of International Symposia Controlled Release Bioact. Material, 1993;20:490–1
   Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev, 2001;47(2–3):165–96
   PubMed Web of Science ®Google Scholar
• Muller RH, Lucks JS. Arzneistofftrager aus festen Lipidteilchen, Feste Lipidnanospharen (SLN). European Patent No. 0605497, 1996
   Google Scholar
• Muller RH, Maaßen S, Werghens H, Specht F, Lucks JS. Cytotoxicity of magnetite loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles (SLN). Int J Pharm, 1996;138:85–94
   Web of Science ®Google Scholar
• Muller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev, 2007;59(6):522–30
   PubMed Web of Science ®Google Scholar
• Sanson BJ, Lensing AW, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonge E, Brenner B, Dulitzky M, Nielsen JD, Boda Z, et al. Safety of low-molecular-weight heparin in pregnancy: A systematic review. Thromb Haemost, 1999;81(5):668–72
   PubMed Web of Science ®Google Scholar
• Saupe A, Gordon KC, Rades T. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int J Pharm, 2006;314(1):56–62
   PubMedGoogle Scholar
• Schaefer H, Lademann J. The role of follicular penetration. A differential view. Skin Pharmacol App Skin Physiol, 2001;14(1):23–27
   PubMedGoogle Scholar
• Song YK, Kim CK. Topical delivery of low molecular weight heparin with surface charged flexible liposomes. Biomaterials, 2006;27:271–80
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm, 2004;278(1):71–77
   PubMed Web of Science ®Google Scholar
• Sznitowska M, Janicki S. Percutaneous absorption of heparin: A critical review of experimental results. Pol Merkuriusz Lek, 2000;7:58–63
   PubMedGoogle Scholar
• Sznitowska M, Janicki S, Williams AC. Intracellular or intercellular localizationof the polar pathway of penetration across stratum corneum. Pharm Sci, 1998;87(9):1109–14
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Boonme P, Souto EB, Muller RH, Junyaprasert VB. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J Control Release, 2008;128(2):134–41
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul V, Souto EB, Junyaprasert VB, Müller RH. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10: Development, physicochemical characterization and in-vitro release studies. Eur J Pharm Biopharm, 2007;67:141–48
   PubMed Web of Science ®Google Scholar
• Ulrich AS. Biophysical aspects of using liposomes as delivery vehicles. Biosci Rep, 2002;22:129–50
   PubMed Web of Science ®Google Scholar
• Wang JX, Sun X, Zhang ZR. Enhanced brain targeting by synthesis of 3′,5′-dioctanoyl-5-fluoro-2′-deoxyuridine and incorporation into solid lipid nanoparticles. Eur J Pharm Biopharm, 2002;54(3):285–90
   PubMed Web of Science ®Google Scholar
• Warwick D, Bannister GC, Glew D, Mitchelmore A, Thornton M, Peters TJ, Brookes S. Perioperative low-molecular-weight heparin. Is it effective and safe? J Bone Joint Surg, 1995;77–B(5):715–19
   Web of Science ®Google Scholar
• Weiner AL. Liposomes for protein delivery: Selecting manufacture and development processes. Immunomethods, 1994;4(3):201–9
   PubMedGoogle Scholar
• Xia Q, Saupe A, Muller RH, Souto EB. Nanostructured lipid carriers as novel carrier for sunscreen formulations. Int J Cosmet Sci, 2007;29(6):473–82
   PubMedGoogle Scholar
• Zhang J, Purdon CH, Smith EW. Solid lipid nanoparticles for topical drug delivery. Am J Drug Del, 2006;4(4):215–20
   Google Scholar
• Zhao XL, Yang CR, Yang KL, Li KX, Hu H-Y, Chen DW. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil. Drug Dev Ind Pharm, 2010;36(7):773–80
   PubMed Web of Science ®Google Scholar